메뉴 건너뛰기
Deutsche Apotheker Zeitung
Volumn 140, Issue 12, 2000, Pages 1293-1294
Celecoxib und Rofecoxib sind magenverträglicher als konventionelle NSAR

(1)  Wasielewski, Susanne a  

a NONE
Author keywords

[No Author keywords available]
Indexed keywords

EID: 4243541482     PISSN: 00119857     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (1)
References (3)
  • 1
    • 0033601079 scopus 로고    scopus 로고
    • Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDS
    • Langmann, M. J., et al.: Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDS. J. Am. Med. Assoc. 282, 1929-1933 (1999).
    • (1999) J. Am. Med. Assoc. , vol.282 , pp. 1929-1933
    • Langmann, M.J.1
  • 2
    • 0033601084 scopus 로고    scopus 로고
    • COX-1-sparing NSAIDS - Is the enthusiasm justified?
    • Peterson, W. L., B. Cryer: COX-1-sparing NSAIDS - is the enthusiasm justified? J. Am. Med. Assoc. 282, 1961-1963 (1999).
    • (1999) J. Am. Med. Assoc. , vol.282 , pp. 1961-1963
    • Peterson, W.L.1    Cryer, B.2
  • 3
    • 0033601089 scopus 로고    scopus 로고
    • Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis
    • Simon, L. S., et al.: Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis. J. Am. Med. Assoc. 252, 1921-1928 (1999).
    • (1999) J. Am. Med. Assoc. , vol.252 , pp. 1921-1928
    • Simon, L.S.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.